Have COPD and allergies? This research study might be for you!

You may qualify if you: 

• Are over 40 
• Have been diagnosed with COPD by your healthcare provider 
• Have a history of flare-ups or ongoing symptoms
• Currently use inhalers on a daily basis 
• Are willing to be tested for common indoor allergies

Unfortunately, you will not be able to participate if you:

• Are on another injected medication for allergies or lung disease 
• Recently had certain lung surgeries 
• Are pregnant or breastfeeding
• Are participating in another study with a drug intervention

The study team will determine if the study is a safe fit for you.

If you qualify for the study, you will:

• Receive study medication or placebo by injection every 2–4 weeks for 12 months 
• Continue your current COPD treatments 
• Attend clinic visits and complete health surveys 
• Receive close medical monitoring throughout the study 
• Have a follow-up phone call one month after your last visit

Total time in the study: about 14–16 months

For in-person visits, compensation is available for time and travel.

COPD-OMA is sponsored by the American Lung Association, the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, and Genentech.